Tianjin Lisheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 204.3% in First Three Quarters of 2023

Tianjin Lisheng Pharmaceutical Co.,Ltd. (天津力生制药股份有限公司) (002393.SZ) reported a net profit of 342.7 million yuan in the first three quarters of 2023, up 204.3% year-on-year.

Meanwhile, the company posted 911.6 million yuan in revenue, up 1.1% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 919.5 million yuan in total liabilities, with a liability-to-asset ratio of 16.5%.